Ephedrine and its salts in single entity products.

in preparations containing no more than 8 mg per unit dose, with a label recommending no more than 8 mg/dose or 32 mg/day and for use not more than 7 days, and indicated for nasal congestion.

Approval Date: April 23, 2006

Schedule: II

Footnote: